Stock Warrant
WARRANTBriaCell Therapeutics Corp. Warrant expiring 2031
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
BCTXL is BriaCell Therapeutics Corp. (Healthcare) — a non-dividend-paying stock. Trading at $0.96.
Stock snapshot
| Price | $0.96 |
| Market cap | — |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About BCTXL
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Related non-dividend companies
Other non-dividend stocks investors research alongside BCTXL. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is BCTXL's current stock price?
BCTXL (BriaCell Therapeutics Corp.) is currently trading at $0.96.
Does BCTXL pay a dividend?
BCTXL (BriaCell Therapeutics Corp.) does not currently pay a regular dividend.
Track BCTXL in DiviDrip
Add BCTXL to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search BCTXL and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.